{"transactions":[{"id":3529176,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":128201,"kind":"organization","name":"Omega Fund V, L.P.","position":1,"cik":"0001641354","reported_name":"Omega Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128202,"kind":"organization","name":"Omega Fund V GP, L.P.","position":2,"cik":"0001641355","reported_name":"Omega Fund V GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128203,"kind":"organization","name":"Omega Fund V GP Manager, Ltd.","position":3,"cik":"0001641348","reported_name":"Omega Fund V GP Manager, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157659,"kind":"person","name":"Mitsak Anna Guyer","position":4,"cik":"0001758535","reported_name":"Mitsak Anna Guyer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2019-05-13T21:03:50.000Z","date":"2019-05-09","kind":"exercise","acquired":false,"shares":5136986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are held directly by Omega Fund V, L.P. (\"Omega V\"). The reported securities may be deemed to be beneficially owned by each of Omega Fund V GP, L.P. (\"Omega V GP\"), as the general partner of Omega V, and Omega Fund V GP Manager, Ltd. (\"Omega V GP Manager\"), as the general partner of Omega V GP. Otello Stampacchia, Richard Lim, Anne-Mari Paster and Claudio Nessi (the \"Omega Directors\") are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Annie Mitsak, a member of the Issuer's board of directors, has no voting or investment control over any of the shares held by Omega V.  Each of Omega V GP, Omega Fund V GP Manager, the Omega Directors and Annie Mitsak disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":582408},"source":{"system":"sec-edgar","filing":"0000899243-19-013261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1563880/000089924319013261/doc4.xml","form_type":"4"}},{"id":3529175,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":128201,"kind":"organization","name":"Omega Fund V, L.P.","position":1,"cik":"0001641354","reported_name":"Omega Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128202,"kind":"organization","name":"Omega Fund V GP, L.P.","position":2,"cik":"0001641355","reported_name":"Omega Fund V GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128203,"kind":"organization","name":"Omega Fund V GP Manager, Ltd.","position":3,"cik":"0001641348","reported_name":"Omega Fund V GP Manager, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157659,"kind":"person","name":"Mitsak Anna Guyer","position":4,"cik":"0001758535","reported_name":"Mitsak Anna Guyer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T21:03:50.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":481000,"price":10,"value":4810000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are held directly by Omega Fund V, L.P. (\"Omega V\"). The reported securities may be deemed to be beneficially owned by each of Omega Fund V GP, L.P. (\"Omega V GP\"), as the general partner of Omega V, and Omega Fund V GP Manager, Ltd. (\"Omega V GP Manager\"), as the general partner of Omega V GP. Otello Stampacchia, Richard Lim, Anne-Mari Paster and Claudio Nessi (the \"Omega Directors\") are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Annie Mitsak, a member of the Issuer's board of directors, has no voting or investment control over any of the shares held by Omega V.  Each of Omega V GP, Omega Fund V GP Manager, the Omega Directors and Annie Mitsak disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any."}],"balance_after":1063408,"source":{"system":"sec-edgar","filing":"0000899243-19-013261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1563880/000089924319013261/doc4.xml","form_type":"4"}},{"id":3529174,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":128201,"kind":"organization","name":"Omega Fund V, L.P.","position":1,"cik":"0001641354","reported_name":"Omega Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128202,"kind":"organization","name":"Omega Fund V GP, L.P.","position":2,"cik":"0001641355","reported_name":"Omega Fund V GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128203,"kind":"organization","name":"Omega Fund V GP Manager, Ltd.","position":3,"cik":"0001641348","reported_name":"Omega Fund V GP Manager, Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157659,"kind":"person","name":"Mitsak Anna Guyer","position":4,"cik":"0001758535","reported_name":"Mitsak Anna Guyer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T21:03:50.000Z","date":"2019-05-09","kind":"exercise","acquired":true,"shares":582408,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities are held directly by Omega Fund V, L.P. (\"Omega V\"). The reported securities may be deemed to be beneficially owned by each of Omega Fund V GP, L.P. (\"Omega V GP\"), as the general partner of Omega V, and Omega Fund V GP Manager, Ltd. (\"Omega V GP Manager\"), as the general partner of Omega V GP. Otello Stampacchia, Richard Lim, Anne-Mari Paster and Claudio Nessi (the \"Omega Directors\") are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Annie Mitsak, a member of the Issuer's board of directors, has no voting or investment control over any of the shares held by Omega V.  Each of Omega V GP, Omega Fund V GP Manager, the Omega Directors and Annie Mitsak disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any."}],"balance_after":582408,"source":{"system":"sec-edgar","filing":"0000899243-19-013261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563880/000089924319013261/doc4.xml","form_type":"4"}},{"id":3534819,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":157659,"kind":"person","name":"Mitsak Anna Guyer","position":1,"cik":"0001758535","reported_name":"Mitsak Anna Guyer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-08T21:00:42.000Z","date":"2019-05-07","kind":"grant","acquired":true,"shares":23684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 7, 2019, effective upon the pricing of the Issuer's initial public offering. This option is scheduled to vest as to (i) 50% of the underlying shares on the earlier of (A) the first anniversary of the date of grant and (B) the date of the first annual meeting of stockholders of the Issuer held following the date of grant and (ii) the remaining 50% of the underlying shares on the earlier of (A) the second anniversary of the date of grant and (B) the date of the second annual meeting of stockholders of the Issuer held following the date of grant."}],"balance_after":23684,"derivative":{"exercise_price":10,"expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":23684},"source":{"system":"sec-edgar","filing":"0000899243-19-012651","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1563880/000089924319012651/doc4.xml","form_type":"4"}}]}